Personalized Medicine Research Program Publications and Presentations

Publications

2018

  • Nadauld LD, Ford JM, Pritchard D, Brown T. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions. Health Affairs 37(5): 751-756, 2018. Original Publication
  • Kaplan H, Berry A, Rinn K, Ellis E, Birchfield G, Wahl T, Liu X, Tameishi M, Beatty JD, Dawson P, Mehta V, Holman A, Atwood M, Alexander S, Bonham C, Summers L, Khalil I, Hayete B, Wuest D, Zheng W, Liu Y, Wang X, Brown TD. Machine learning approach to personalized medicine in breast cancer patients: Development of data-driven, personalized, causal modeling through identification and understanding of optimal treatments for predicting better disease outcomes. Cancer Res July 1 2018 78 (13 Supplement) 5299-5299; DOI:10.1158/1538-7445.AM2018-5299. Original Publication
  •  Madhavan S, Subramaniam S, Brown TD, Chen JL. Art and Challenges of Precision Medicine: Interpreting and Integrating Genomic Data Into Clinical Practice DOI: 10.1200/EDBK_200759 American Society of Clinical Oncology Educational Book 38 (May 23, 2018) 546-553. Original Publication

2017

  • Brown TD. 2017. Role of Community-Based Genomics Programs, FCO Precision Oncology 2017:1, 1-3. Original Publication
  • Brown TD, Tameishi M, Liu X, Scanlan JM, Beatty JD, Drescher CW, Pagel JM, Gold PJ, Alexander S, Summers LK, Brindle M, Varghis N, Yates J, Fondren KN, Birchfield GR, Dong DE, Benkers TL, Wahl TA, Ramsey SD, Berry AB. Analysis of Reimbursement for Next Generation Sequencing (NGS) on Patients’ Tumors in the Context of a Personalized Medicine Program. J Clin Oncol 35, 2017 (suppl; abstr 6506). Google Scholar Original Publication
  • Brown TD, Tittel PD, Gold PJ, Drescher CW, Pagel JM, Beatty JD, Grevstad P, Iriarte D, Alexander S, Brindle M, Liu X, O'connor D, Tameishi M, Xu D, Berry AB. 2017. Impact of a personalized medicine research program (PMRP), using targeted tumor profiling and a cloud based clinical trials matching platform, on clinical decision-making. Proc AACR 58; 255, Abstract #997, 2017. Original Publication

2016

  • Benkers TL, Berry AB, Tameishi M, Lessig M, Brown TD. 2016. Next generation sequencing (NGS) of primary central nervous system tumors (CNST) as part of a personalized medicine cancer research program (PMRP) identifies alterations with sensitivity to targeted inhibitors. Proc Am Soc Clin Oncol 35:2066, 2016. Google Scholar   Original Publication
  • Drescher CW, Berry AB, Beatty JD, Xu D, Liu X, Zhang M, Keith K, Scanlan JM, Pagel JM, Gold PJ, Markowitz D, Benkers TL, Bonham C, Tameishi M, Brown TD. 2016. TP53 gain of function mutations identified by tumor sequencing performed in the context of a community based personalized medicine cancer program. Eur J Cancer 69 (suppl; S146), EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 2016. Original Publication

2015

  • Brown TD, Gold PJ, Drescher C, Pagel J, Beatty JD, Grevstad P, Iriarte D, Tameishi M, Smith A, Xu D, Berry AB. 2015. Rapid implementation of a personalized medicine research program (PMRP), using a targeted next-generation sequencing (NGS) assay, in the community setting. J Clin Oncol 33, 3015(suppl; abstr e22055). Google Scholar   Original Publication
  • Thomas Brown, MD, MBA, “Building a personalized medicine program”. Oncology Issues, September/October, 2015. Original Article.

Presentations and Panel Discussions

2018

  • Anna Berry, MD, Panel: Challenges to Realizing the Full Potential of Precision Medicine: Precision Medicine: Expanding Opportunities”. Cancer Care State of Cancer Care in America Event Series, American Society of Clinical Oncology,  Washington, DC, January 31st, 2018.
  • Thomas Brown, MD, “Blazing the Precision Medicine Trail: Data Interoperability and Sharing Across the Ecosystem”. Oral presentation, HIMSS, March 5th, 2018. View Slides
  • Anna Berry, MD, Integrating gene panels and EMR records to develop treatment pathways and cancer cure frameworks on large scales. Oral presentation, BioData World, West 2018, March 13th, 2018.
  • Subramaniam S. “Precision Oncology in a Community Setting”. ASCO 2018 Educational Session: Precision Medicine Informatics.

2017

  • Carlo Bifulco, MD, Anna Berry, MD, “Incorporating the AMP Guidelines in Molecular Reporting: Best Practices”. Webinar. GenomeWeb, December 14th, 2018.
  • Thomas Brown, MD, MBA, Panel Dialogue:  “Scientific Wellness and the Future of Healthcare”.  Personalized Lifestyle Medicine Institute’s 5th Annual Thought Leaders Consortium.  Renton, Washington, October 13-14, 2017. View recording (login required).
  • Thomas Brown, MD, MBA, Panel 2 (Oncologist Panel): “Reinventing How We Diagnose, Treat and Monitor Cancer”. UBS Genomics 2.0 Summit, Park City, Utah, August 15-16, 2017.
  • Thomas Brown, MD, MBA, “Analysis of reimbursement (R) for nest generation sequencing (NGS) on patients’ tumors in the context of a personalized medicine program”. Abstract and oral presentation, American Society of Clinical Oncology Annual Meeting, June 5th, 2017. View Slides
  • Anna Berry, MD, “Advancing precision medicine in oncology: the molecular pathologist’s role”. Oral presentation, Personalized Medicine World Conference, Duke, May 25th, 2017.
  • Anna Berry, MD, “Driving next generation diagnostics and precision medicine into the clinic”. Oral presentation, BioData USA West, April 26th, 2017.
  • Thomas Brown, MD, MBA, “"The Future of Cancer Care through Biologic Profiling and Big Data". Institute for Systems Biology’s 16th Annual International Symposium, Seattle. April 4th, 2017. View recording.
  • Thomas Brown, MD, MBA, “Impact of personalized medicine research program (PMRP), using targeted tumor profiling and cloud based clinical trials matching platform, on clinical decision making” (abstract accepted for oral presentation, American Association for Cancer Research, April 2nd, 2017). View Slides.
  • Anna Berry, MD, “Launching a precision medicine program: real-world solutions to practical challenges”. Oral presentation. The Business of Personalized Medicine, March 28th, 2017.
  • Thomas Brown, MD, MBA, “Health IT for automated enterprise-scale clinical trial matching”. Oral presentation. Healthcare Information and Management Systems Society, February 19th, 2017.

2016

  • “TP53 gain of function mutations identified by tumor sequencing performed in the context of a community based personalized medicine cancer program”. Poster presentation. EORTC-NCI-AACR, Munich, November 29th – December 2nd, 2016. View Poster.
  • Thomas Brown, MD, MBA, “Adventures in precision medicine: the good, the ugly and the real”. Webinar, Healthcare Information and Management Systems Society (HIMSS), November 16th, 2016. 
  • Thomas Brown, MD, MBA, “Creating a precision healthcare system: opportunities and challenges”. Oral presentation, Personalized Medicine Lifestyle Institute, October 22nd, 2016. View recording (login required).
  • Tara Benkers, MD, “Next generation sequencing (NGS) of primary central nervous system tumors (CNST) as part of a personalized medicine cancer research program (PMRP) to identify alterations with sensitivity to targeted inhibitors”. Poster presentation. American Society of Clinical Oncology, June 3rd, 2016. View poster.
  • Paul Tittel, “Precision medicine at Swedish / providence: cancer genomics, informatics innovation & beyond”. Oral presentation. Health Management Academy, April, 2016 and February, 2016. 

2015

  • Thomas Brown, MD, MBA, “Personalized medicine: the intersection of novel agents, new technology and empowered patients”. Oral presentation, Association of Community Cancer Centers National Oncology Conference, October 21st, 2015.